Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- Parsons Corporation Secures New Engineering Contract in California
- Sanctuary Wealth Enhances Client Experience with BNY's Wove
- Volvo and DHL Launch Pioneering Autonomous Freight Operations
- Stevie Wonder Foundation Hosts Special Event with Wayfinder Services
- Explore Innovative Strategies at Business Architecture Summit
- CyberArk Launches Innovative Open-Source Tool for AI Security
- CTC Global Welcomes Steve Zogas as New CFO to Propel Growth
- Organigram to Share Fiscal 2024 Results with Stakeholders
- Crédit Agricole Financement de l'Habitat's Repurchase Plans
- ID5 and OpenX Join Forces to Enhance Digital Advertising Reach
- Stora Enso Oyj Announces Dividend Payment Update for 2024
- Opportunity for Investors: Class Action Lawsuit Against Marqeta
- Stora Enso Announces Second Dividend Payment for 2023
- Arctic Wolf Partners with Immersive Labs for Cybersecurity Opportunities
- Legal-Bay Launches Efficient Funding Application for Clients
- Forbright Bank Celebrated as Leader in Eco-Friendly Banking
- Roundhill Investments Announces Upcoming ETF Distributions
- American Consumers Target Financial Goals for 2025 Resolutions
- Construction Industry Thrives Amid Economic Changes in Q3 2024
- Lowe's 2025 Total Home Strategy: Steps Toward Future Growth
- Lyfegen Secures CHF 5 Million to Boost Global Expansion Efforts
- Socket Mobile Enhances Developer Experience with CaptureSDK Update
- Unlocking Precision Medicine Insights: IDEAYA's R&D Day Agenda
- Grocery TV and Hy-Vee Launch Largest Retail Media Network
- West Pharmaceuticals Welcomes Janet Haugen to Its Board
- Understanding the Guidelines for AI Regulation in Healthcare
- Growth Prospects in the Advanced Elastomers Market to 2029
- Lyfegen Attracts CHF 5 Million to Expand Drug Rebate Solutions
- Innovative Drug Delivery Solutions: Serina's New Approach
- Hemp Protein Powder Demand Surge Fuels Market Growth
- Exploring the Rising Demand in the Demagnetizers Market
- Composite Material Testing Market Growth Driven by Innovations
- KANZHUN LIMITED Reports Impressive Revenue Growth in Q3
- Norsk Hydro's Share Buyback Program: Key Highlights and Impact
- Nokia Unveils 5G Banshee Flex Radio for Combat Communication
- BitFuFu Inc. Expands Operations with New Long-Term Mining Leases
- Transforming Construction: Blackwell 3D's Innovative Initiative
- MannKind's Afrezza Inhalation Powder Approved for Indian Market
- Titan Mining Advances Financial Strategy for Future Growth
- Significant Ethanol Production Milestone Achieved in Europe
- Chris Morris Takes the Helm as CEO of European Wax Center
- Relay Therapeutics Reveals Positive Interim Data for RLY-2608
- Leadership Transition at Karolinska Development Amid Growth Plans
- Octopus AIM VCT plc Reports Impressive Share Value Insights
- Octopus AIM VCT 2 plc: Recent Updates on NAV and Contact Info
- Understanding the Disclosures of Warpaint London Plc In Detail
- Mega Matrix Unveils Engaging Drama License to Wed and Kill
- iOnctura Advances Treatment Options for Uveal Melanoma Patients
- Rossell Techsys Limited Honored by Lockheed Martin for Excellence
- Zetrix Partners with Astron to Launch Digital ID Solutions